Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Enhabit, Inc ( (EHAB) ).
Enhabit, Inc. reported strong financial results for the second quarter of 2025, with notable growth in both revenue and Adjusted EBITDA. The company saw a 1.3% increase in home health admissions and a 12.3% rise in hospice average daily census year over year. Enhabit also reduced its bank debt by $10 million, enhancing its financial position. The company’s strategic initiatives have positioned it well for continued success in the latter half of 2025.
The most recent analyst rating on (EHAB) stock is a Buy with a $9.50 price target. To see the full list of analyst forecasts on Enhabit, Inc stock, see the EHAB Stock Forecast page.
Spark’s Take on EHAB Stock
According to Spark, TipRanks’ AI Analyst, EHAB is a Neutral.
The overall stock score is driven by significant financial challenges and bearish technical indicators. While there are positive signs from recent earnings and corporate events, poor valuation and operational issues weigh heavily on the stock’s attractiveness.
To see Spark’s full report on EHAB stock, click here.
More about Enhabit, Inc
Enhabit, Inc. is a leading provider in the home health and hospice care industry, focusing on delivering comprehensive healthcare services to patients in their homes.
Average Trading Volume: 618,636
Technical Sentiment Signal: Sell
Current Market Cap: $338.8M
For a thorough assessment of EHAB stock, go to TipRanks’ Stock Analysis page.